Then, we still found that LL/2 was resistant but CT26 was sensitive to αPD-L1scFv-hFc immunotherapy in the syngeneic tumor mice, whereas tumor inhibition appeared after three times αPD-L1scFv-hFc intraperitoneal injection (Fig. 7C). Here, DDX53 is linked to neoplasm.